NCT02487784

Brief Summary

The primary aims of this study are to compare the clinical and histologic results of bone regeneration with a cancellous block allograft versus MinerOss Cortico cancellous particulate allograft mixed with autogenous bone chips after 4 months of healing. Titanium reinforced hd-PTFE (Cytoplast) membrane GBR will be used to cover the bone grafts. Specific Aim 1: To compare the baseline to 4 month change in clinical ridge width and height. Specific Aim 2: To compare the histologic percent of vital and nonvital bone and trabecular space at 4 months. The primary outcome variable is the change in horizontal ridge width. The secondary outcomes are the change in ridge height and the percent histologic composition of the augmented site.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2015

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 19, 2015

Completed
12 days until next milestone

First Posted

Study publicly available on registry

July 1, 2015

Completed
1 month until next milestone

Study Start

First participant enrolled

August 1, 2015

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
Last Updated

January 3, 2018

Status Verified

December 1, 2017

Enrollment Period

10 months

First QC Date

June 19, 2015

Last Update Submit

December 31, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Horizontal ridge width changes

    Site width (horizontal) changes by comparing the pre- to the 4 month post- augmentation dimensions of hard tissues.

    4 months

Secondary Outcomes (2)

  • Vertical ridge height changes

    4 months

  • Histologic composition of the graft

    4 months

Study Arms (2)

Particulate allograft + autogenous bone.

EXPERIMENTAL

In the test arm of the study the treatment will include a mix of MinerOss CorticoCancellous Particulate allograft + autogenous bone chips.

Procedure: Particulate allograft + autogenous bone chips

Block allograft

ACTIVE COMPARATOR

The positive control treatment will include a block allograft plus Mineross corticocancellous particulate allograft.

Procedure: Block allograft

Interventions

A cancellous block allograft plus corticocancellous particulate allograft will be used as the positive control treatment.

Also known as: Cancellous block allograft
Block allograft

The test arm of this study will include a mix of particulate bone allograft and autogenous bone chips.

Also known as: Particulate + ABC
Particulate allograft + autogenous bone.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • At least a one tooth area with a ridge defect, treatment planned to receive a dental implant. The site must be bordered by at least one tooth.
  • Healthy person that is at least 18 years old.
  • Patient understands and signs an informed consent approved by the University of Louisville Human Studies Committee.

You may not qualify if:

  • Patients with debilitating systemic diseases, diseases that significantly affect the periodontium, or psychological problems that would interfere with treatment.
  • Previous head and neck radiation or chemotherapy within the previous 12 months.
  • Patients with known allergy to any of the materials that will be used in the study.
  • Smokers.
  • Patients on oral bisphosphonates \> 3 years or any IV bisphosphonates.
  • Patients who are pregnant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Alveolar Bone Loss

Interventions

abacavir

Condition Hierarchy (Ancestors)

Bone ResorptionBone DiseasesMusculoskeletal DiseasesPeriodontal AtrophyPeriodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Officials

  • Henry Greenwell, DMD, MSD

    Director of Graduate Periodontics, School of Dentistry, University of Louisville.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Graduate Periodontics

Study Record Dates

First Submitted

June 19, 2015

First Posted

July 1, 2015

Study Start

August 1, 2015

Primary Completion

June 1, 2016

Study Completion

June 1, 2016

Last Updated

January 3, 2018

Record last verified: 2017-12